Der Vortrag „Sekundäre dilatative Kardiomyopathie“ von Joseph Alpert, MD ist Bestandteil des Kurses „Kardiomyopathie“.
Which of the following findings is less likely in a patient with ischemic dilated cardiomyopathy without significant obstructive valvulopathy?
Which of the following drugs is most likely to cause dilated cardiomyopathy at therapeutic levels?
Which of the following is not a treatment option for dilated cardiomyopathy?
| 5 Sterne |
|
5 |
| 4 Sterne |
|
0 |
| 3 Sterne |
|
0 |
| 2 Sterne |
|
0 |
| 1 Stern |
|
0 |